PharmAthene Inc. now knows how much money it stands to get in its long-running lawsuit with Siga Technologies Inc.: A judge Thursday said Siga must pay PharmAthene $195 million and $30,663 per day in interest if Siga loses its appeal to the Delaware Supreme Court.
The case dates to 2006, when Annapolis-based PharmAthene sued New York-based Siga after the companies’ planned merger fell apart. PharmAthene claimed it was entitled to some of the profits from Tecovirimat, Siga’s smallpox antiviral.
{iframe}http://www.bizjournals.com/washington/blog/2015/01/pharmathene-awarded-195-million-court-victory-with.html{/iframe}